Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine. The group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases. In late October 2017, Reuters announced that Novartis would acquire the company for $3.9 billion, paying $41 per ordinary share and $82 per American depositary share representing a 47 percent premium. On January 22, 2018, Novartis AG announced the successful completion of the tender offer by its subsidiary, Novartis Groupe France S.A. More information...
According to PR-model, adacap.com is ranked 1,363,272nd in multilingual Wikipedia, in particular this website is ranked 923,548th in English Wikipedia.
The website is placed before untitled.org.il and after jaroo.com.au in the BestRef global ranking of the most important sources of Wikipedia.
